From Residual Activity to Inactivation Parameters
A preincubation assay measures how enzyme activity changes while enzyme is exposed to an inhibitor for a specified time. Repeating the experiment at different inhibitor concentrations separates two features of mechanism-based inactivation: the maximum inactivation rate and the concentration scale over which that rate is approached. These are commonly summarized by \(k_{\mathrm{inact}}\) and \(K_I\).
The first step is to estimate an observed inactivation rate, \(k_{\mathrm{obs}}\), at each inhibitor concentration. The second is to fit the concentration–rate relationship. A good numerical fit is not enough by itself: the chosen concentrations and the quality of the activity measurements must also contain enough information to estimate both parameters.
The Assay Model and Its Assumptions
Let \(A(t)\) denote measured enzyme activity after preincubation for time \(t\), and let \(A_0\) denote the corresponding activity in a matched control without inhibitor. If activity is proportional to the amount of active enzyme, and active enzyme is lost at a constant observed rate during the preincubation, the model is
For a single time point with a positive, normalized activity fraction, this gives \(k_{\mathrm{obs}}=-\ln(A(t)/A_0)/t\). With multiple time points, \(k_{\mathrm{obs}}\) is usually estimated as the negative slope of a regression of \(\ln(A(t)/A_0)\) on \(t\). The regression should include a zero-time or matched control measurement, and the activity values should be corrected for assay background where appropriate.
To connect \(k_{\mathrm{obs}}\) to inhibitor concentration, suppose inhibitor binding is rapid relative to inactivation, the free inhibitor concentration remains approximately constant during preincubation, and the fraction of enzyme in the inhibitor-bound state is \(I/(K_I+I)\). Suppose only that bound fraction undergoes irreversible inactivation, at rate \(k_{\mathrm{inact}}\). Then the resulting observed rate is
Here \(I\) should represent the relevant free inhibitor concentration, not automatically the nominal concentration added to the tube. The earlier material on unbound inhibitor concentrations at the enzyme site motivates checking that distinction. This model also assumes that inhibitor depletion is negligible, that reversible inhibition does not contaminate the activity measurement after preincubation, and that enzyme recovery during the incubation is negligible. If these conditions are not reasonable, the fitted parameters may not describe the intended inactivation process.
Estimating an Observed Rate
Worked Example: Calculating kobs From a Preincubation Time Course
In a hypothetical assay, a no-inhibitor control has activity 100 units. At one inhibitor concentration, measured activities after 0, 5, 10, and 15 minutes are 100, 74.1, 54.9, and 40.7 units. Assume the assay is linear in active enzyme and the normalized activities follow exponential loss during preincubation. Calculate the rate from each nonzero time.
The activity fractions are 0.741, 0.549, and 0.407. Using \(k_{\mathrm{obs}}=-\ln(A(t)/A_0)/t\):
The close agreement is consistent with an observed rate of about \(0.05995\ \mathrm{min}^{-1}\) at this inhibitor concentration. With actual replicate data, fitting the slope across all time points is generally preferable to treating each time point as a separate rate estimate. That regression uses the full time course and makes departures from a straight line in the log-activity plot easier to see.
The slope method assumes that log activity is approximately linear in time at each inhibitor concentration. A systematic curve in that plot can indicate a changing inhibitor concentration, multiple kinetic phases, measurement problems, or failure of the single-rate model. A very low residual activity also requires caution: background signal can dominate, and taking its logarithm can produce a misleading rate.
Fitting kinact and KI
Once a \(k_{\mathrm{obs}}\) estimate is available at each concentration, fit the saturable model across concentrations. In a typical analysis, nonlinear regression estimates \(k_{\mathrm{inact}}\) and \(K_I\) by minimizing a suitable residual criterion between observed and predicted rates. The parameters should be constrained to be positive. Weights can be used when rate estimates have substantially different variances; the weights should reflect the measurement-error model rather than be chosen merely to improve the appearance of a fit.
Worked Example: Recovering Both Parameters From Rates at Several Concentrations
Consider hypothetical observed rates at inhibitor concentrations of 0.5, 1, 2, 4, and 8 micromolar: 0.024, 0.040, 0.060, 0.080, and 0.096 per minute, respectively. Suppose these rates are precise and follow the saturable model. Estimate \(k_{\mathrm{inact}}\) and \(K_I\).
The model is \(k_{\mathrm{obs}}=k_{\mathrm{inact}}I/(K_I+I)\). The observations at 1 and 4 micromolar give two equations:
Rearranging the first equation gives \(k_{\mathrm{inact}}=0.040(K_I+1)\). Rearranging the second gives \(k_{\mathrm{inact}}=0.020(K_I+4)\). Equating these expressions,
Substitution gives \(k_{\mathrm{inact}}=0.040(2.00+1)=0.120\ \mathrm{min}^{-1}\). Checking the remaining concentrations confirms the fit: at 0.5 micromolar the prediction is \(0.120(0.5)/(2.00+0.5)=0.0240\ \mathrm{min}^{-1}\); at 2 micromolar it is \(0.0600\ \mathrm{min}^{-1}\); and at 8 micromolar it is \(0.0960\ \mathrm{min}^{-1}\). The 4-micromolar prediction is \(0.0800\ \mathrm{min}^{-1}\). Thus these idealized data match \(k_{\mathrm{inact}}=0.120\ \mathrm{min}^{-1}\) and \(K_I=2.00\ \mathrm{\mu M}\). Real data would generally be fitted by nonlinear regression rather than solved exactly from two selected points.
Why the Concentration Range Matters
The model’s shape explains when both parameters can be estimated. At concentrations much lower than \(K_I\), \(K_I+I\) is approximately \(K_I\), so
Low-concentration data therefore mainly identify the ratio \(k_{\mathrm{inact}}/K_I\), not each parameter separately. At concentrations much higher than \(K_I\), \(k_{\mathrm{obs}}\) approaches \(k_{\mathrm{inact}}\); those observations inform the limiting rate, but if all concentrations are very high, the data provide little information about where the curve bends and hence about \(K_I\). A useful design includes concentrations below, near, and above the anticipated \(K_I\), while avoiding concentrations so high that activity becomes too low to measure reliably.
This is a practical identifiability issue: several combinations of parameters may predict nearly the same rates over the observed range. A narrow confidence interval produced by an overly restrictive fit does not fix a design that contains little information about one parameter. Inspect the observed and fitted rates, uncertainty intervals, and whether the data actually show both the rising portion and the approach toward a plateau.
Worked Example: Recognizing Weak Identification at Low Concentrations
Suppose hypothetical rates are measured only at 0.1, 0.2, and 0.4 micromolar. Compare two possible parameter pairs: \(k_{\mathrm{inact}}=0.120\ \mathrm{min}^{-1}, K_I=2.00\ \mathrm{\mu M}\), and \(k_{\mathrm{inact}}=0.300\ \mathrm{min}^{-1}, K_I=5.00\ \mathrm{\mu M}\).
The first pair predicts rates of \(0.120(0.1)/(2.0+0.1)=0.005714\), \(0.120(0.2)/(2.0+0.2)=0.01091\), and \(0.120(0.4)/(2.0+0.4)=0.02000\ \mathrm{min}^{-1}\). The second predicts \(0.300(0.1)/(5.0+0.1)=0.005882\), \(0.300(0.2)/(5.0+0.2)=0.01154\), and \(0.300(0.4)/(5.0+0.4)=0.02222\ \mathrm{min}^{-1}\). Those predictions are similar at these low concentrations, especially if assay uncertainty is substantial.
The pairs have the same low-concentration ratio: \(0.120/2.00=0.300/5.00=0.0600\ \mathrm{min}^{-1}\mathrm{\mu M}^{-1}\). At 20 micromolar, however, the first predicts \(0.120(20)/(2.0+20)=0.1091\ \mathrm{min}^{-1}\), whereas the second predicts \(0.300(20)/(5.0+20)=0.2400\ \mathrm{min}^{-1}\). A sufficiently reliable high-concentration measurement would distinguish them. The lesson is not that 20 micromolar is always an appropriate assay concentration, but that measurements spanning the curve are needed to separate the parameters.
Diagnostics, Alternatives, and Limitations
A sound analysis checks both stages of estimation. First, plot log normalized activity against time separately for each inhibitor concentration. Approximately straight lines support a single \(k_{\mathrm{obs}}\) per concentration; curvature or systematic residual patterns call that assumption into question. Second, plot estimated \(k_{\mathrm{obs}}\) against the relevant inhibitor concentration with the fitted curve. Look for systematic deviations, an apparent plateau supported by measurements, and adequate observations around the bend. Large uncertainty or strong dependence between the fitted parameters is a warning that the concentration range has not identified both reliably.
There are two common fitting strategies. The two-stage approach estimates \(k_{\mathrm{obs}}\) from each time course and then fits the concentration–rate curve. It is transparent and useful for diagnostics, but the second stage must account for uncertainty in the estimated rates. Alternatively, a joint fit uses all activity observations directly with the prediction
A joint fit can propagate information from the full time courses, provided its residual-error model is appropriate. It does not remove the need for informative concentrations or valid assay assumptions. Another alternative is reciprocal linearization, which rewrites the rate equation using \(1/k_{\mathrm{obs}}\) and \(1/I\). Although this produces a straight-line form algebraically, it changes the error structure and can give disproportionate influence to low rates. Direct nonlinear fitting is generally preferable.
Potential failure modes include inhibitor depletion, an inaccurate free-concentration estimate, enzyme instability in the no-inhibitor control, reversible inhibitor carryover into the activity readout, and activity values near the assay’s lower limit. Replicates, matched controls, adequate dilution or inhibitor removal before readout, and an informative time and concentration range help assess these issues. If the model or assay conditions are wrong, a fitted \(k_{\mathrm{inact}}\) and \(K_I\) can still be returned by software, but they should not be treated as reliable mechanistic estimates.
Check Your Understanding
Try each question, then check the short solutions below.
- A normalized activity is 0.60 after 8 minutes. Under the exponential-loss model, calculate \(k_{\mathrm{obs}}\).
- What does \(K_I\) represent in the saturable rate model, and why should it not automatically be called an equilibrium dissociation constant?
- Why are measurements only at concentrations much smaller than \(K_I\) generally insufficient to estimate \(k_{\mathrm{inact}}\) and \(K_I\) separately?
- Name one diagnostic for the time-course model and one diagnostic for the concentration–rate model.
Solutions. 1. \(k_{\mathrm{obs}}=-\ln(0.60)/(8\ \mathrm{min})=0.06385\ \mathrm{min}^{-1}\). 2. \(K_I\) is the concentration at which \(k_{\mathrm{obs}}\) is half its limiting value; it is an apparent kinetic parameter and need not equal an equilibrium binding constant. 3. At low \(I\), \(k_{\mathrm{obs}}\approx(k_{\mathrm{inact}}/K_I)I\), so the data mainly identify the ratio. 4. For time courses, inspect whether log normalized activity is approximately linear in time; for concentration–rate data, inspect the fitted curve, residual pattern, parameter uncertainty, and whether observations cover the bend and plateau.